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Abstract 
 
 
 
EXAMINATION OF PLATELET ADHESION BY STREPTOCOCCUS SANGUINIS 
 
By Brian Christopher Mahoney, B.S. 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science 
at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2009 
 
Director: Todd O. Kitten, Ph.D. 
Associate Professor, VCU School of Dentistry 
 
 
 
Streptococcus sanguinis is a leading cause of infective endocarditis. Bacterial adhesion to 
platelets is likely important in the pathogenesis of infective endocarditis. Bacterial cell wall-
anchored (Cwa) proteins may mediate this adhesion. To begin to test this hypothesis, S. 
sanguinis adhesion to platelets was examined in vitro. The requirement of 12 Cwa proteins for S. 
sanguinis-platelet adhesion was individually assessed, measuring adhesion of purified platelets 
to polystyrene wells coated with S. sanguinis strain SK36 or 12 isogenic Cwa protein mutants. 
Significantly fewer platelets adhered to wells coated with one mutant strain, VT1614. However, 
results of a whole-cell enzyme-linked immunosorbent assay (ELISA) showed that 8 mutants, 
including VT1614, adhered in significantly lower numbers to wells than did SK36. After 
accounting for unequal bacterial numbers, we determined there was no significant difference in 
platelet adhesion among the strains. This suggests that none of the Cwa proteins examined were 
required for S. sanguinis-platelet adhesion. 
  
 
Introduction 
 
Streptococcus sanguinis 
Streptococcus sanguinis, formerly referred to as Streptococcus sanguis, is a gram-
positive, facultative anaerobe belonging to the viridans group of streptococci. Other members of 
this group include Streptococcus gordonii and Streptococcus parasanguinis. Members of the 
viridans streptococci, including S. sanguinis, are initial bacterial colonizers of the oral cavity (1, 
2). While oral streptococci, which constitute ~20% of the normal human oral flora, are abundant 
at most oral sites, S. sanguinis preferentially colonizes the tooth surface (3). The dental enamel 
of a tooth is composed of hydroxyapatite crystals. On the surface of the tooth, the hydroxyapatite 
crystals are covered in salivary proteins (the salivary pellicle), which provides a wealth of 
binding sites used by oral streptococci. S. sanguinis has been shown to bind specific salivary 
proteins, including salivary IgA and α-amylase, on the tooth surface (2, 4). In the oral cavity, S. 
sanguinis is recognized as having a benign, or even advantageous, role by competing with other 
oral bacteria that cause dental caries and periodontitis (5, 6). Outside of its native niche, however, 
S. sanguinis is one of the foremost causative agents of bacterial infective endocarditis (IE), a life-
threatening endothelial infection.  
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Infective endocarditis 
Infective endocarditis is a rare—but serious—infection characterized by the formation of 
septic masses of platelets and fibrin, otherwise referred to as vegetations, on the surfaces of the 
cardiac endothelium. Streptococcal species are the causative agents in approximately 42% of 
bacterial IE cases (7, 8). Furthermore, of all the oral streptococci, S. sanguinis is most often 
implicated as the cause of native-valve IE (9-12). The mean incidence of IE has been reported to 
be 3.6 cases per 100,000 per year (13), and appears to increase with age. The reported incidence 
of fewer than 5 cases per 100,000 in individuals less than 50 years of age increases to more than 
15 cases per 100,000 in individuals over 65 years of age (13). Although there have been 
improvements in diagnosis and medical treatment over the years, IE is still associated with high 
morbidity and mortality, which has been reported to range from 11-30% (13, 14). Death can be 
attributed to congestive heart failure or embolization of vegetation components to major organs 
(14, 15). Such high morbidity and mortality could be due to the fact that prophylaxis, diagnosis, 
and treatment of IE are still a major challenge in clinical practice (14). 
Early diagnosis of IE relies heavily on blood cultures, which test for the presence of IE-
causing microorganisms, and echocardiograms, which may indicate the presence of a vegetation 
(16). Later diagnosis may be made through bacterial culture from, or histological examination of, 
an excised vegetation found during open heart surgery or at autopsy (16). Other minor criteria for 
IE diagnosis include predisposing cardiac conditions and intravenous drug use, which is a risk 
factor for IE in some populations (16). If left untreated, IE is uniformly fatal. Treatment may 
involve the use of antimicrobial therapy, surgical intervention, and monitoring by 
echocardiography (16). Effective treatment often requires collaboration among physicians from 
multiple disciplines (14). 
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Pathogenesis of infective endocarditis 
Much is known about the overall pathogenesis of IE. In order to cause IE, a pathogenic 
organism must first be introduced into the bloodstream. Bacteria in the mouth can enter the 
bloodstream, causing a transient bacteremia, in a number of ways. Examples include dental 
procedures such as tooth extractions, oral surgery, periodontal treatment, and cleanings (17-20). 
More often though, transient bacteremias occur as the result of everyday activities, such as 
brushing, flossing, and chewing(17-20). 
Bacteria in the bloodstream cause IE primarily at sites of pre-existing damage to the 
cardiac valves or endothelium. Therefore, individuals with  prosthetic cardiac valves, congenital 
heart disease (CHD), heart transplantation, previous case of IE, or rheumatic heart disease may 
be predisposed to develop IE from a transient bacteremia (15). Following trauma to the cardiac 
endothelium, exposure of the sub-endothelial matrix and its extracellular matrix (ECM) proteins 
prompts the normal deposition of platelets and fibrin, forming a clot at the site of injury (21). 
This is referred to as nonbacterial thrombotic endocarditis (NBTE). At this point, the clot, or 
sterile vegetation, provides a surface to which IE-causing bacteria in the bloodstream may adhere. 
Once adhered to the vegetation, the bacteria stimulate the deposition of more platelets and fibrin. 
This sequesters them within a vegetation of increasing size where they can proliferate, resulting 
in IE. 
 
Prophylaxis for infective endocarditis 
As no vaccine for prevention of IE exists, other methods of prevention are required. It 
was previously thought that dental procedures were a main cause of IE. Consequently, over the 
past 50 years the American Heart Association (AHA) has published guidelines recommending 
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antimicrobial prophylaxis for at-risk patients prior to invasive dental procedures (22). These 
guidelines have been repeatedly updated. The most recent update dramatically reduced the 
number of pre-existing conditions for which antimicrobial prophylaxis is recommended (16). 
These new guidelines take into account more current studies, which suggest that IE cases caused 
by oral bacteria frequently result from transient bacteremias caused by routine daily activities 
(23-28). Furthermore, there is a lack of evidence as to the efficacy of prophylactic antibiotics in 
preventing IE. Even if antibiotic prophylaxis before dental procedures were 100% effective, it 
would likely only prevent an extremely small number of IE cases (15). It is not reasonable for 
individuals at risk for developing IE to use antibiotics on a daily basis. Therefore, a reduction in 
the frequency of daily bacteremias through maintenance of good oral hygiene and prevention of 
dental disease has been emphasized (29-33). The high morbidity and mortality associated with IE 
along with the lack of effective prophylaxis warrants further research into other prevention 
methods, such as a vaccine. 
 
Platelets and thrombosis 
 Human blood platelets play an important role in hemostasis and thrombosis. Platelets are 
the smallest (3.6 x 0.7 μm) and most numerous (3x108 – 4x108 mL-1 blood) cells in the blood (34, 
35). They are metabolically active, anucleated cells formed by megakaryocytes in the bone 
marrow. In primary hemostasis, platelets recognize sites of injury by adhering to collagen and 
glycoproteins in the exposed sub-endothelial matrix. Under low-shear conditions, initial platelet 
adherence is mediated by two main collagen receptors on the platelet surface: glycoprotein (GP) 
VI and GPIa/IIa (36, 37). Under high-shear conditions, the von Willebrand factor (vWF) receptor, 
GPIb-IX-V, is primarily responsible for mediating platelet adhesion (36, 37).  
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Platelet adhesion through any of these receptors leads to platelet activation. Biochemical 
signal transduction in activated platelets causes shape change, granule secretion, and activation 
of receptors that promote adhesion and aggregation. The activated receptor GPIIb/IIIa binds 
fibrinogen, which cross-links activated platelets, forming a platelet aggregate (35). Activated 
platelets secrete granules containing platelet activating molecules, such as adenosine diphosphate 
(ADP), serotonin, and thromboxane A2 (TxA2) (35). These secondary agonists amplify platelet 
activation, attracting more platelets to the site of injury. During secondary hemostasis, thrombin 
is generated on cell membranes at the site of thrombus formation. Thrombin converts soluble 
fibrinogen into fibrin, which forms strands. These fibrin strands interweave throughout the 
developing platelet thrombus, resulting in a stable platelet-fibrin clot (35). In NBTE lesions, the 
platelet-fibrin clot is free of bacteria. However, in IE, bacteria have adhered to and colonized the 
platelet-fibrin surface. Therefore, bacterial adherence to this surface is thought to be an important 
event in the pathogenesis of IE. 
 
Gram-positive bacterial surface exposed proteins are potential virulence factors in infective 
endocarditis 
On the bacterial surface, there are specific molecules that may act as adhesins by 
interacting with host cell receptors or host extracellular matrix molecules. These include the cell 
wall-anchored (Cwa) proteins, which are the major surface-exposed protein class in gram-
positive bacteria. This class of proteins is typified by covalent linkage to the peptidoglycan layer 
of the bacterial cell wall. Both adhesive and enzymatic functions have been credited to 
streptococcal Cwa proteins. Some Cwa proteins considered to be important in pathogenesis have 
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been grouped as MSCRAMMs, or microbial surface components recognizing adhesive matrix 
molecules of host tissue and host cells (38). 
 Several staphylococcal Cwa protein MSCRAMMs, such as clumping factor A (ClfA) and 
fibronectin-binding proteins A and B (FnbA, FnbB) of the gram-positive bacterium 
Staphylococcus aureus, have been demonstrated to be important for pathogenesis in 
experimental IE (21). FnbA and FnbB both bind fibronectin in vitro (39), and ClfA has 
fibrinogen-binding capacity in vitro (40, 41); both of these proteins are soluble in blood, and 
fibronectin is present in the extracellular matrix of host tissues (42). Furthermore, the 
Staphylococcus aureus proteins clumping factor A (ClfA) and FnbA, when expressed on the 
surface of Lactococcus lactis, a poorly pathogenic, food-grade bacterium, increased the 
adherence of L. lactis to both immobilized fibrinogen and fibronectin in vitro (43).  
Multiple streptococcal Cwa protein MSCRAMMs have been identified as well. In S. 
gordonii, the high-molecular-mass cell surface polypeptides CshA and CshB have been 
suggested to act as multifunctional adhesins (44). Mutants of Streptococcus gordonii, in which 
the genes encoding CshA and/or CshB were inactivated, were deficient in binding to 
immobilized human fibronectin (44). Another S. gordonii adhesin, the sialic acid-binding protein, 
Hsa, has been shown to possess fibronectin-binding capacity in vitro and to contribute to 
infectivity under competitive conditions in an animal model of IE (45).  
 
Bacterial cell surface proteins as vaccine candidates 
Bacterial cell surface proteins, including Cwa proteins, are of interest not only for their 
roles in disease, but also as potential targets for vaccine therapy. Localized on the cell surface, 
they have the potential to be accessible to the host immune response. In S. aureus, cell wall-
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anchored surface proteins have been tested as vaccinogens in a murine model of abscess 
formation. It was determined that immunization with four surface proteins generated significant 
protective immunity that correlated with the induction of opsonophagocytic antibodies (46). If 
adhesive Cwa proteins are important mediators of pathogenesis, antibodies directed against them 
could prevent infection by either of two separate mechanisms: (i) opsonization, resulting in 
phagocytosis and killing of the bacteria; or (ii) prevention of bacterial adherence by interference 
with adhesin function. 
No investigation has yet examined the effects of immunization with S. sanguinis surface 
proteins. Perhaps this is because there is a lack of information regarding their potential role in S. 
sanguinis-IE. Studies that examine the role of various S. sanguinis Cwa proteins in IE may 
provide an indication of their relative potential as vaccine candidates. Since IE carries such high 
morbidity and mortality, primary prevention is very important and the development of an 
effective IE vaccine would be of great significance. 
 
 Platelet interactions with gram-positive bacteria 
Bacterial-platelet adherence has been suggested to be an important early event in the 
pathogenesis of IE (47). Initial bacterial colonization of sites of endovascular damage may be 
mediated by adhesion to platelets present in the sterile vegetation. Platelet interactions by several 
IE-causing gram-positive bacteria (Figure 1) have been reported. Previous studies have shown 
that the S. aureus proteins clumping factor A, clumping factor B, protein A and fibronectin-
binding protein (FnbA) all bind to platelets  (48-51). More recently, a high-molecular-mass 
protein called SraP was shown to promote binding of S. aureus cells to platelets and to enhance  
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Figure 1. Platelet interactions with surface proteins on gram-positive bacteria. Reported 
interactions between bacterial surface proteins and platelet receptors are shown for three gram-
positive infective endocarditis-causing bacteria; Streptococcus gordonii, Streptococcus sanguinis, 
and Staphylococcus aureus. Question marks indicate as yet, unidentified platelet receptors. 
Bacterial adhesion to or aggregation of platelets resulting from the interactions is indicated next 
to each association.
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virulence in a rabbit model of endocarditis (52). Furthermore, reduced platelet binding in vitro by 
S. aureus has been associated with reduced virulence in a rabbit model of IE (53). This was an 
important finding because it suggests a link between a platelet-binding phenotype in vitro and 
virulence in an animal model of endocarditis. Since endocarditis is characterized by platelet 
vegetations, bacterial activation and resulting aggregation of platelets has been suggested to be a 
virulence factor (54).The S. aureus Cwa proteins ClfA and ClfB, as well as the serine-aspartate 
repeat protein SdrE, are capable of inducing platelet aggregation when expressed in non-
aggregating L. lactis (50). The S. aureus protein SraP is a homolog of the S. gordonii Cwa 
protein GspB. The cell-surface glycoproteins GspB and Hsa of S. gordonii have been reported to 
mediate platelet adherence by directly interacting with platelet receptor GPIb (55, 56).  
 
Platelet interactions with Streptococcus sanguinis 
The investigation of potential S. sanguinis virulence factors for IE has included 
examination of adhesion and aggregation of platelets. Some studies have examined S. sanguinis-
platelet adhesion, although these studies have not directly examined this property in relation to 
endocarditis virulence. Scheld et al. previously reported that S. sanguinis strain M-5 adheres to 
platelet-fibrin matrixes in vitro, utilizing bacterial colonies grown on the surface of platelet-fibrin 
matrixes as a measure of adherence (57). They also reported that the presence of platelets in a 
fibrin matrix increased adherence of S. sanguinis over that observed with fibrin alone, which 
suggested a possible bacteria-platelet interaction (57). There have since been multiple reports of 
S. sanguinis binding platelets in vitro (56, 58-61). The results of a study examining S. sanguinis-
platelet binding by flow cytometry demonstrated that streptococcus-platelet binding is rapid, 
reversible, and saturable, which suggests a specific receptor-ligand interaction (61). Given the 
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adhesive properties of many Cwa proteins, some of which have been shown to bind platelets in 
related species, it is plausible that these proteins could contribute to platelet adhesion in S. 
sanguinis via such an interaction.  
A number of studies support this suggestion. A S. sanguinis cell-surface protein related to 
the cell surface hydrophobicity (Csh) protein A of S. gordonii, a reported adhesin, has been 
implicated in platelet adhesion and aggregation of platelets (62). It was reported that a CshA 
mutant derived from S. sanguinis strain 133-79, which is a strain that is positive for both platelet 
adhesion and aggregation phenotypes (Adh+, Agg+), showed a loss of both phenotypes (62). 
Additionally, a S. sanguinis Cwa protein has been reported to mediate adhesion to platelets via a 
specific receptor on the platelet surface. A serine-rich protein, designated SrpA, was shown to 
bind glycocalicin (GC), the extracellular domain of the platelet vWF receptor glycoprotein Ibα 
(GPIbα) (56). Furthermore, a S. sanguinis SrpA- mutant strain reportedly exhibited reduced 
adherence to platelets, suggesting this Cwa protein may contribute to platelet binding by S. 
sanguinis (56). 
Other studies have also examined S. sanguinis-platelet aggregation. In S. sanguinis, a cell 
wall platelet aggregation-associated protein (PAAP), more recently identified as CbpA, has been 
reported to interact with a receptor on platelets to induce platelet aggregation (62-65). 
Additionally, S. sanguinis-induced platelet aggregation has been linked to vegetation 
enlargement and virulence in experimental IE. In a rabbit model of IE, inoculation with a strain 
of Streptococcus sanguinis (133-79), which induced rabbit platelets to aggregate in vitro (Agg+ 
phenotype), consistently caused endocarditis with a more severe clinical course than inoculation 
with an Agg- strain (L50) or the Agg+ strain pretreated with an antibody against its platelet 
aggregation-associated protein (PAAP; class II) (54). This suggested that the PAAP may be an 
 11
important virulence factor. Herzberg et al. (59) reported that selective adhesion of S. sanguinis to 
platelets was apparently required for aggregation, suggesting a link between the two phenotypes. 
Unfortunately, however, this experiment has not been repeated with a defined PAAP mutant, 
suggesting caution in its interpretation. 
A study by Plummer et al. (56) was the first to examine the potential contribution of a 
Cwa protein to S. sanguinis-platelet adhesion in the strain SK36. This is an important strain for 
several reasons. First, although SK36 is an oral isolate, it has been previously demonstrated in 
our lab to be virulent in experimental animal models of IE (66, 67). Second, it possesses a 
platelet aggregation phenotype. Finally, its genome was recently sequenced (68), which has 
allowed for the identification of genes encoding putative adhesins, including Cwa proteins. SK36 
has 33 predicted Cwa proteins (67) and mutants of 12 of these proteins were tested in this study 
for their ability to adhere to platelets. 
 
Project goal 
Platelets are a main component of the vegetation colonized by bacteria in IE. It has been 
suggested that S. sanguinis adherence to platelets is an important early step in the pathogenesis 
of IE, and cell-surface proteins, such as Cwa proteins, are thought to mediate this adherence. For 
this study, we hypothesized that certain Cwa proteins contribute to S. sanguinis-platelet adhesion 
and set out to test that hypothesis. There have been few previous investigations of this topic 
reported. If multiple Cwa proteins were discovered to contribute to S. sanguinis-platelet binding 
it could lead to new methods of IE prevention by interference with S. sanguinis-platelet 
interaction, as well as further understanding of the processes of bacterial adhesion and 
colonization in IE. 
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Materials and Methods 
 
Bacterial strains  
Bacterial strains used in the following experiments are listed in Table 1. Streptococcus 
sanguinis strain SK36 is an oral isolate originally obtained from the University of Aarhus, 
Denmark (68). All S. sanguinis mutant strains were derived from SK36 (Table 1). S. sanguinis 
strain VT1614, a srpA mutant, was obtained from Dr. Hui Wu, University of Alabama (56). All 
other S. sanguinis mutants (Table 1) were created using a directed signature-tagged mutagenesis 
approach and have been described previously (67).  
 
Bacterial cultivation and cell preparation 
All liquid cultures of S. sanguinis strains were grown in brain-heart infusion (BHI) broth 
(Difco) for 16 hours at 37°C under microaerobic conditions (6% 02, 80% N2, 7% CO2, 7% H2). 
Liquid cultures of E. coli strain DH10B were grown aerobically in LB broth (BD) for 16 hours at 
37°C. Liquid cultures of L. lactis strain MG1363 were grown aerobically in M17 growth media 
(Difco) + 0.5% (w/v) glucose for 16 hours at 30°C. For each strain, a 16-hour liquid culture was 
combined with sterile glycerol (70% culture + 30% glycerol), aliquoted, and frozen at -75°C.  In 
all experiments, bacterial overnight cultures were inoculated using individual, thawed aliquots 
originating from a single culture maintained at -75°C. 
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Table 1. Bacterial strains used 
 
 
Bacteria/Strain   Description           Reference 
_______________________________________________________________________ 
 
Escherichia coli 
      
DH10B Laboratory strain  (69)  
 
Lactococcus lactis 
  
MG1363 Food-grade lactic acid bacteria  (70) 
  
 
Streptococcus sanguinis 
  
SK36 Human plaque isolate  (71) 
 
VT1614    ΔsrpA, derived from SK36      (56) 
 
Cwa 15    SSA_1023::magellan2  (67) 
 
Cwa 25    SSA_1063::magellan2  (67) 
 
Cwa 7     SSA_1633::magellan2  (67) 
 
Cwa 6     SSA_1634::magellan2  (67) 
 
Cwa 3     SSA_1663::magellan2  (67) 
 
Cwa 13    SSA_0303::magellan2  (67) 
 
Cwa 33    SSA_0904::magellan2  (67) 
 
Cwa 9     SSA_0956::magellan2  (67) 
 
Cwa 8     SSA_1632::magellan2  (67) 
 
SSA_1635 mutant   SSA_1635::aad9   (67) 
 
Cwa 30    SSA_1666::magellan2  (67) 
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Bacterial cells were intrinsically labeled with [3H]thymidine by adding 25 μL (25 μCi) of 
[3H]thymidine (GE Healthcare) to a plastic culture tube, containing 5 μL of cells and 5 mL BHI 
liquid broth, and incubating overnight.  
All cells were harvested by centrifugation at 5k x g for 10 minutes at 4°C. Cells were 
then washed with 5 mL PBS (150 mM NaCl, 16 mM Na2HPO4, 4 mM NaH2PO4; pH 7.3) and 
harvested as before. Cells were washed again with 1.5 mL PBS, centrifuged at 14,000 rpm, for 2 
minutes at room temperature, and then resuspended in 1 mL PBS. Non-labeled cells of each 
strain were serially diluted 10-fold and plated in triplicate on growth media + agarose (Difco). 
SK36 was grown on plates containing BHI + agar and incubated for two days at 37°C under 
microaerobic conditions (6% O2). DH10B was grown on plates containing LB + agar and 
incubated overnight under conditions described for liquid culture. MG1363 was grown on plates 
containing M17 + agar + 0.5% (w/v) glucose and incubated for two days under conditions 
described for liquid culture. Colony counts were used to determine the number of colony 
forming units (CFUs) mL-1 in the cell preparations for each strain.  
For the S. sanguinis-platelet adhesion assay, cultured cells were harvested by 
centrifugation at 5k x g for 10 minutes at 4°C. Bacteria were washed in 5 mL PBS, centrifuged 
again as described above, and finally suspended in 1 mL PBS. The optical densities (660 nm) of 
the cell suspensions were adjusted to 1.8 (~2.0 × 109 CFU mL-1) using a Helios Gamma  
spectrophotometer (Unicam). For each strain, 1 mL of concentrated cells was sonicated for 1 
minute 30 seconds at 50% power using an ultrasonic homogenizer (BioLogics, Inc.). 
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 Preparation of platelets 
Blood collection and platelet preparation techniques were based on those described 
previously (57, 60, 72). For examination of S. sanguinis adherence to platelet-fibrin matrixes via 
colony counting, platelet-rich plasma was prepared as follows. Eleven mL of blood bank whole 
anti-coagulated blood (Virginia Blood Donor Services) was centrifuged at 500 x g for 4 minutes 
at room temperature in a 15 mL polystyrene tube. The uppermost layer was removed and 
designated platelet-rich plasma (PRP). For all other experiments involving platelets, fresh blood 
was drawn from the antecubital vein of healthy, adult volunteer donors using a 21-gauge 
butterfly needle. Donors had not taken any aspirin, ibuprofen or anticoagulant medications in the 
previous two weeks. All experiments involving donors were performed with Institutional Review 
Board approval and complied with all university regulations. 
For experiments measuring adherence of 3H-labeled bacteria to platelet-fibrin matrixes, 
whole blood was collected in 4.5 mL-draw tubes (BD Vacutainers) containing 3.2% sodium 
citrate (citrate solution, 0.5 mL; sodium citrate, 12.35 mg; citric acid, 2.21 mg) at a blood:sodium 
citrate ratio of 9:1. Anticoagulated whole blood was centrifuged at 500 x g for 4 minutes at room 
temperature. The upper layer of platelet-rich plasma (PRP) was aspirated into a separate 
polypropylene tube. 
For experiments using gel-filtered platelets, whole blood was collected in 6 mL-draw BD 
Vacutainers containing ACD solution B (trisodium citrate, 13.2 g L-1; citric acid, 4.8 g L-1 ; and 
dextrose, 14.7 g L-1; 1.0 mL) at a blood: ACD ratio of 6:1. Anticoagulated whole blood was 
centrifuged at 150 x g for 10 minutes at room temperature. The upper layer of PRP was aspirated 
into a separate polypropylene tube.   
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Platelet separation from plasma proteins by gel filtration was based on methods 
previously described by Kerrigan, et al 2002 (60). The pH of collected PRP was adjusted to 6.5 
with ACD.  Prostaglandin-E1 was added to a final concentration of 2 μmol L-1 in order to 
minimize platelet clumping by inhibiting activation. The plasma was centrifuged at 630 x g for 
ten minutes at room temperature. The supernatant, platelet-poor plasma (PPP), was removed and 
the remaining platelet pellet was gently re-suspended in 2 mL JNL buffer (6 mM dextrose, 130 
mM NaCl, 9 mM NaHCO3, 10 mM Na Citrate, 10 mM Tris Base, 3 mM KCl, 900 μM MgCl2, 2 
mM HEPES). The suspended platelets were added to a 20 mL disposable chromatography 
column (Bio-Rad) containing 5 mL Sepharose 2B-300 (Sigma-Aldrich) at room temperature.  
The column was previously equilibrated with 20 mL JNL buffer. Eluted platelet fractions were 
collected in 0.5 mL volumes and manually counted under a phase-contrast microscope using a C-
Chip DHC-N01-2 disposable hemocytometer (INCYTO). Platelet fractions were pooled and the 
concentration adjusted to approximately 2 ×107 platelets mL-1. 
 
Treatment of SK36 with a tissue solubilizer for microscopic examination 
SK36 cells from an overnight culture were washed and concentrated in PBS, as before. 
TS-2 (0.5 mL) and SK36 cells (0.25 mL) were combined in a 1.5 mL plastic tube. Control SK36 
cells (0.25 mL) were combined with PBS (0.50 mL) in a separate tube. Cells in both tubes were 
mixed by vortexing and incubated under a step-wise increase in temperature. The tubes were 
incubated at room temperature for 30 minutes and then at 37°C for 45 minutes. Tubes were 
vortexed again, and further incubated at 37°C for 1 hour and 30 minutes. Tubes were then placed 
in a 45°C water bath for 2 more hours. After a total incubation period of 4 hours and 15 minutes, 
the tubes were vortexed and cells examined microscopically. Five μL of each cell suspension 
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was placed on a glass microscope slide, covered with a coverslip and examined under a phase 
contrast microscope (Olympus BH-2; 40 X objective). 
  
Bacterial adhesion to platelet-fibrin matrixes 
Preparation of the platelet-fibrin matrixes is based on the methods previously described 
by Scheld et al. (57). For examination of S. sanguinis adherence to platelet-fibrin matrixes via 
colony counting, platelet-fibrin matrixes were prepared as follows. In each well of a 24-well 
polystyrene plate (Costar), the following were combined: 70 μL PRP, 30 μL bovine thrombin 
(Dade Behring; 100 units ml-1), and 30 μL of 0.2 M CaCl2. The mixtures were incubated for 30 
minutes at 37°C, which was followed by inoculation with 350 μL prepared SK36 cells. The plate 
was incubated for 15 minutes at 37°C in a shaking incubator (120 cycles min.-1). After 
incubation, wells were washed three times, sequentially, with 350 μL PBS on a rotary shaker for 
5 minutes per wash. After removing the wash buffer, the surface of each well was overlaid with 
640 μL  BHI + low melting point agarose (Promega), which cooled for 20 minutes at room 
temperature. The plate was incubated for 48 hours at 37°C and colonies were counted. 
For examination of 3H-labeled S. sanguinis adherence to platelet-fibrin matrixes by liquid 
scintillation counting, the matrixes were prepared as follows. In each well of a 96-well filter 
plate (Millipore), the following were combined: 50 μL of PRP, 40 μL of a 1:1 solution of bovine 
thrombin (Dade Behring; 100 units ml-1) and 0.2 M CaCl2. The mixtures were incubated for 30 
minutes at 37°C. The wells were gently washed twice with 100 μL PBS containing 1% BSA and 
then incubated with 100 μL of the BSA solution for 60 minutes at room temperature. The BSA 
solution was removed and 75 μL of 3H-labeled cells were added to each well and incubated at 
37°C for varying durations. The wells were washed three times with 100 μL PBS. The plate was 
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then placed in a -75°C freezer for 25 minutes to solidify the gel-like platelet-fibrin matrixes. A 
Millipore Multiple Punch System was used to transfer the contents of each well into an 
individual scintillation vial containing 0.75 mL TS-2 tissue solubilizer (RPI). For use in creating 
a standard curve for each strain, 75 μL of 3H-labeled cells were added in triplicate to scintillation 
vials containing 0.75 mL TS-2 and serially diluted two-fold. All vials were placed in a shaking 
incubator for 4 hours at 50°C and 100 cycles/minute, per TS-2 manufacturer recommendations. 
Following incubation, the vials were allowed to cool to room temperature overnight. The 
following morning, 200 μL of 10% glacial acetic acid were added to each vial to neutralize the 
strongly basic TS-2 and help prevent chemiluminescence. Each vial was filled with 5 mL of 
BioSafe II liquid scintillation cocktail and mixed thoroughly. Finally, all vials were wiped with 
an anti-static cloth, loaded in a liquid scintillation counter and their contents measured in 
triplicate for the presence of 3H using the 3H-detection program on the scintillation counter. 
Initial measurements of radioactivity were expressed in counts per minute (CPM). To 
obtain bacterial adherence values, the triplicate measurements of each vial were averaged.  Next, 
the average values of all replicate vials were calculated. The average of three background vials, 
each containing no radioactivity, was then subtracted. A standard curve was developed in order 
to determine the relationship between the measured CPM and the corresponding number of 
adherent CFUs. Using the standard curve, all CPM values were converted to the number of 
adherent CFUs. Finally, bacterial adherence to the platelet-fibrin matrix was expressed as a 
percentage of the total number of bacterial CFUs originally added to the platelet-fibrin matrix. 
Significance was determined by a One-way Analysis of Variance (ANOVA) and a Dunnett 
multiple-comparisons post test, with a P value < 0.05 representing a significant difference. 
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S. sanguinis-platelet adhesion assay 
A platelet adhesion assay was used to measure adherence of platelets to S. sanguinis 
immobilized on a polystyrene surface. This assay is based on the methods previously described 
by Kerrigan et al. (60) and makes use of the intracellular platelet enzyme, acid phosphatase, for 
quantification. One hundred μL of S. sanguinis (~2.0 × 109 cfu mL-1) cells suspended in PBS 
were added to six wells/strain in a 96-well polystyrene plate (Greiner Bio-One). Next, 100 μL of 
2.5% (w/v) BSA in PBS were added to six wells of the same plate, which was then incubated for 
2 hours at 37°C. The wells were washed twice with 100 μL of the BSA solution and then 
incubated in 100μL of the same blocking solution for 1 hour at 37°C. The wells were washed 
three times in JNL buffer to remove any unbound protein. 50 μL of freshly gel-filtered platelets 
(~2 ×107 platelets mL-1) were added to three wells/strain and the platelets were allowed to adhere 
for 30 minutes at 37°C. Unused gel-filtered platelets were set aside. All wells were gently 
washed three times with 100 μL of JNL buffer to remove nonadherent platelets.  For use in 
creating a standard curve, 50 μL of unused gel-filtered platelets were added in quadruplicate to 
untreated wells on the plate and serially diluted two-fold. Next, 100 μL of lysis buffer containing 
a substrate for acid phosphatase [0.1 M Na acetate (pH 5.5), 0.1% Triton X-100, 10 mM p-
nitrophenol phosphate] were added to each well and the plate was incubated for 2 hours at 37°C. 
The reaction was stopped with 50 μL of 1 M NaOH.  50 μL of JNL buffer were added to non-
standard curve wells  in order to equalize volumes. Light absorbance was measured on a 
FLUOstar microtiter plate reader (BMG) at 410 nm. Initial absorbance values were too high to 
detect differences between strains so all wells were diluted 1:4 in JNL buffer and absorbance was 
re-measured. 
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Data was expressed by first subtracting the average values of three wells/strain not 
treated with platelets from those that were treated with platelets. Using the standard curve, all 
absorbance values were converted to number of adherent platelets. Next, the average number of 
adherent platelets to the three BSA treated wells was subtracted from the number adherent to 
bacteria treated wells. Finally, the average number of adherent platelets to all strains was 
expressed as a percentage of the average number adherent to SK36. Significance was determined 
by a One-way Analysis of Variance (ANOVA) and a Dunnett multiple-comparisons post test, 
with a P value of <0.05 representing a significant difference. 
 
Chemical fixation of cells by glutaraldehyde treatment 
Treatment of S. sanguinis cells with glutaraldehyde was used in an attempt to chemically 
fix the cells to polystyrene wells and tested in the S. sanguinis-platelet adhesion assay. One-
hundred μL of SK36 cells (adjusted to 3 x 109 CFU ml-1) or BSA (2%) (w/v) were added in 
triplicate to a 96-well polystyrene plate (Greiner Bio-One) and incubated for 2 hours at 37°C. 
Without washing, 100 μL of 0.25% (w/v) glutaraldehyde in sterile dH2O were added to each well. 
The plate was incubated for 30 minutes at 37°C. Wells were washed, blocked with BSA and 
otherwise treated as in the platelet adhesion assay (described above). 
 
Whole-cell enzyme-linked immunosorbent assay (ELISA) 
An ELISA was used to measure bacterial adherence to a polystyrene plate surface. The 
assay was performed based on methods previously described (67, 73, 74). For each strain, 100 
μL prepared cells were added in triplicate to a 96-well polystyrene plate (Greiner Bio-One). 
Three background wells were filled with 100 μL of 2.5% (w/v) BSA in PBS. For use in creating 
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a standard curve, 100 μL of prepared SK36 cells were added in triplicate and serially diluted 2-
fold. The plate was incubated for 2 hours at 37°C. Contents of all wells were removed and the 
wells were washed twice in 0.1 mL of TBST-B blocking buffer [10 mM Tris-HCl (pH 8.0), 0.15 
M NaCl, 0.1% (v/v) Tween-20, 2.5% (w/v) BSA]. Wells were then incubated with 0.1mL of 
TBST-B for 1 hour at 37°C. Contents of the wells were removed and replaced with 0.05 mL of 
anti-SK36 polyclonal antiserum (67) diluted 1:25,000 in TBST-B blocking buffer. The plate was 
incubated at room temperature for 2.5 hours and then washed three times with 0.1mL of TBST 
[10 mM Tris-HCl (pH 8.0), 0.15 M NaCl, 0.1% (v/v) Tween-20]. Next, 0.05 mL of alkaline 
phosphatase-conjugated anti-rabbit immunoglobulin G (diluted 1:2,000 in TBST) was added as a 
secondary antibody. The plate was incubated and washed as before.  Bound secondary antibody 
was detected by addition of 0.1 mL of a p- nitrophenylphosphate (p-NPP) substrate solution 
(Kirkegaard & Perry Laboratories, Gaithersburg, MD) according to the manufacturer’s 
instructions.  After ten minutes, a dark straw color developed and the reaction was stopped with 
100 μL of 5% EDTA. Light absorbance at 410 nm was measured using a FLUOstar microtiter 
plate reader (BMG). Resulting absorbance values were adjusted by subtracting the average of 
three background wells. Significance was determined by a One-way Analysis of Variance 
(ANOVA) and a Dunnett multiple-comparisons post test, with a P value of <0.05 representing a 
significant difference. 
 
Combining platelet adhesion and ELISA data 
 The whole-cell ELISA was run simultaneously alongside platelet adhesion experiments. 
The same set of prepared cells was added in both the ELISA and platelet adhesion assay. Data 
from each pair of experiments was combined using the following steps: first, the mean bacterial 
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adherence of each strain to the polystyrene plate surface as a percentage of SK36 adherence was 
calculated from the results of three separate ELISA experiments (Mean 1). In the same way, the 
mean platelet adherence to each strain as a percentage of platelet adherence to SK36 was 
calculated from the results of three separate S. sanguinis-platelet adhesion experiments (Mean 2).  
Next, Mean 1 was divided into Mean 2 and multiplied by 100, yielding a single, adjusted mean 
value of platelet adherence to each strain (Mean 3). This final value of platelet adherence to each 
strain is expressed as a percentage of platelet adherence to SK36. 
After dividing one mean into another, the following equation was used to calculate the 
adjusted standard deviation: 
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Where M1 = Mean 1 with Standard Deviation (S1), M2 = Mean 2 with Standard Deviation (S2), 
and M3 = Mean 3 with Standard Deviation (S3).  
Platelet adherence (Mean 3) was compared between strains. Significance was determined by a 
One-way Analysis of Variance (ANOVA) and a Dunnett multiple-comparisons post test, with  P 
< 0.05 representing a significant difference. 
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Results 
 
 
 
Examination of S. sanguinis adherence to platelet-fibrin matrixes via colony counting 
We wanted to determine the contribution of various SK36 Cwa proteins to platelet 
adhesion. To do this, we first needed to establish that SK36 adheres to platelets in an in vitro 
assay and that we could measure this adhesion. As an indicator of potential platelet adherence, 
we initially tried to measure SK36 adhesion to platelet-fibrin matrixes. Our first approach to 
measuring SK36 adherence to a platelet-fibrin matrix was based on the methods of Scheld, et al. 
(57) and used bacterial colony formation on the surface of a platelet-fibrin matrix as an indicator 
for bacterial adherence. Log-phase SK36 cells were added to wells of a 24-well microtiter dish 
containing freshly prepared platelet-fibrin matrixes and incubated for 15 minutes at 37°C in a 
shaking incubator (120 cycles/min.). Non-adherent cells were washed away and the surface was 
overlaid with BHI + low melting point agarose. After incubation, colonies were counted. Figure 
2 shows the number of SK36 colonies that were observed in the presence (rows A and B) and 
absence (rows C and D) of platelet-fibrin matrixes. Colonies were very small and difficult to 
count when more than about 20 were present in a well. Countable colonies came from wells 
inoculated with bacterial concentrations under 102 CFU mL-1. Similar numbers of colonies were 
counted in wells with and without platelet-fibrin matrixes. This result was not as discouraging as 
might be imagined, as SK36 has been shown to bind well to microtiter plates. However, colonies 
were non-uniform in size and partially obscured by the platelet-fibrin matrix, making counting 
difficult. Moreover, it could be expected that a colony might arise in different instances from  
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Figure 2. SK36 colonies in the presence and absence of platelet-fibrin matrixes. Platelet-fibrin 
matrixes with adherent SK36 were overlaid with BHI + low melting point agarose and incubated 
at 37°C for two days to allow for colony formation. (A) Concentration of SK36 added to each 
well and the number of colonies counted. (B) Actual image of the plate at the time colonies were 
counted. Wells in rows A and B contained matrixes while wells in rows C and D did not. * = 
empty/unused wells. Results shown are from a single experiment. 
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Figure 2. 
A. 
Bacteria Added (CFU/mL)       
  1 2 3 4 5 6 
A 5 x 107 5E+06 5E+05 5E+04 5E+03 5E+02 
B 5E+01 0E+00 * * * *  
C 5E+07 5E+06 5E+05 5E+04 5E+03 5E+02 
D 5E+01 0E+00  *  *  *  * 
         
Colonies Counted      
  1 2 3 4 5 6 
A TNTC TNTC TNTC TNTC TNTC ~35 
B 10 2 * * * *  
C TNTC TNTC TNTC TNTC TNTC 15 
D ~25 0  *  *  *  * 
 
B. 
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different numbers of adherent cells, making quantification difficult. A different approach was 
therefore taken. 
 
Examination of S. sanguinis adherence to platelet-fibrin matrixes via detection of 
radioactively labeled cells—optimization of sample preparation for scintillation counting 
Because measurement of bacterial adhesion to platelet-fibrin matrixes by colony counting 
proved unsatisfactory, we next decided to measure adherence of radioactively labeled cells by 
scintillation counting, as has been done previously (75). Early optimization experiments using 
the scintillation counting technique for detection of 3H-labeled bacteria were plagued by 
inconsistency and increasing CPM in samples over time. Figure 3 shows the results of an 
experiment in which 3H-labeled SK36 cells were added to five vials of liquid scintillation 
cocktail, which were examined by scintillation counting over a period of seven days. With each 
later measurement, the CPM was significantly larger than the measurement that came before it 
(P<0.001, ANOVA). This was unexpected because no additional 3H had been added to the 
samples after day one. Examination of the literature concerning the chemistry and physics of 
scintillation counting revealed that efficient and reproducible counting requires that samples be 
homogeneous not only at the macroscopic level but also at the molecular level (76). This 
suggested the possibility that S. sanguinis cells were continuing to lyse over the course of several 
days’ incubation in the scintillation fluid, which was increasing the efficiency of liquid 
scintillation counting. A biological tissue solubilizer (TS-2) was therefore used to attempt to 
more thoroughly homogenize the samples.  
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Figure 3. Increasing detection of 3H-labeled SK36 cells by scintillation counting over time. 3H-
labeled SK36 cells were added to vials of liquid scintillation cocktail. Using a liquid scintillation 
counter, the amount of 3H in the sample was measured over a period of seven days. Values 
shown (mean + standard deviation) are from five replicate samples. 
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We first examined the effect of TS-2 on non-radiolabeled SK36 microscopically. SK36 
cells from an overnight culture were washed and concentrated in PBS. TS-2 and suspended cells 
were combined at a ratio of 2:1, while control SK36 cells were diluted with PBS at the same 
ratio. All cells were incubated under a step-wise increase in temperature for 4 hours and 15 
minutes with periodic mixing. This protocol was improvised due to a lack of manufacturer 
recommendations at the time. Later experiments utilizing the tissue solubilizer followed 
manufacturer recommendations. After incubation, cells were examined microscopically (Figure 
4). In the control sample, cells were plentiful and arranged mostly in chains. In the sample 
treated with TS-2, there were far fewer cells. Instead, several small clumps, which may or may 
not have contained whole cells, were visible. We next examined the effect of TS-2 on 3H-labeled 
SK36 cells by liquid scintillation counting. TS-2 and 3H-labeled SK36 cells were combined at a 
ratio of  ~7:1 and incubated for 4 hours at 50°C in a shaking incubator (100 cycles/min.). 
Samples were examined by liquid scintillation counting over a period of four days (Figure 5). 
Comparison of the CPM on all days determined that there was no significant difference 
(ANOVA).  
After testing the effect of TS-2 on 3H-labeled S. sanguinis alone, the solubilizer treatment 
was used to dissolve whole platelet-fibrin matrixes with adherent cells. 3H-labeled SK36 cells 
were added to wells of a 96-well microtiter filter plate containing freshly prepared platelet-fibrin 
matrixes and incubated for 30 minutes at 37°C. The matrixes were washed to remove non-
adherent cells, treated with TS-2, and then measured in a liquid scintillation counter for the 
presence of 3H. In one such experiment, the mean CPM from samples treated with TS-2 (8481 ± 
853, mean ± SD) was significantly different from that of samples not treated with the solubilizer  
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Figure 4. Effect of a biological tissue solubilizer (TS-2) on the microscopic appearance of SK36 
cells. (A.) Untreated SK36. (B.) SK36 cells treated with TS-2. Images were taken under a phase 
contrast microscope (40X objective). 
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Figure 4.  
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Figure 5. Effect of a biological tissue solubilizer (TS-2) on the detection of 3H-labeled SK36 
cells by scintillation counting over time. 3H-labeled SK36 cells were treated with TS-2 and the 
amount of 3H was measured in CPM by liquid scintillation counting over a period of four days. 
The values (mean + SD) are from four replicates in one experiment. 
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(4182.7 ± 1743.9, mean ± SD) (P<0.05, Unpaired t test). Based on these results, it appeared that 
treatment of 3H-labeled SK36, both in the presence and absence of platelet-fibrin matrixes, 
increased the reproducibility and sensitivity of 3H detection. The tissue solubilization step was 
therefore included in all subsequent experiments with the bacterial – platelet-fibrin matrix 
adhesion assay. 
 
Bacterial adhesion to platelet-fibrin matrixes 
 Using a bacterial – platelet-fibrin matrix adhesion assay, we measured adherence of 
radioactively labeled cells to a platelet-fibrin matrix by scintillation counting.  One culture of 
cells was grown in the presence of [3H]thymidine and was split into two parts for use in the 
adhesion assay and for development of a standard curve. For the former, 3H-labeled cells were 
added to wells of a 96-well microtiter filter plate containing freshly prepared platelet-fibrin 
matrixes and incubated at 37°C. The matrixes were washed to remove non-adherent cells, treated 
with TS-2, and then measured in a liquid scintillation counter for the presence of 3H. For the 
standard curve, 3H-labeled cells were treated with TS-2 and measured by scintillation counting. 
A replicate overnight culture, grown in the absence of [3H]thymidine, was plated on growth 
media and incubated for measurement of CFUs via colony count. Figure 6 shows a standard 
curve from a single bacteria – platelet-fibrin matrix adhesion experiment and shows the CPM 
detected in samples to which increasing numbers of bacteria were added directly to scintillation 
vials. The standard curve allowed conversion of measured CPM to percent of added bacteria that 
adhered to the matrix. 
 The standard curve was necessary because we determined that different bacteria 
incorporated different amounts of [3H]thymidine into their cells. In one experiment, a culture of  
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Figure 6. Standard curve from a single bacteria – platelet-fibrin matrix adherence experiment. 
3H-labeled SK36 cells, from the same culture used to inoculate platelet-fibrin matrixes, were 
added in increasing concentrations to scintillation vials, treated with TS-2, and counted in a 
liquid scintillation counter. A replicate culture was used for the plating and counting of bacterial 
colonies. 
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3H-labeled MG1363, containing ~1.0 x 108 CFU mL-1, produced 3.96 x 104 CPM. In the same 
experiment, a culture of 3H-labeled SK36, containing the same concentration of CFU mL-1, 
produced 2.36 x 105 CPM. A trendline inserted in each standard curve provided an equation for 
converting CPM into bacterial CFUs. Subsequently, bacterial adherence to the platelet-fibrin 
matrix was expressed as the percentage of adherent CFUs divided by the total number of CFUs 
added to the matrix. Three different bacterial species were tested for their ability to adhere to a 
platelet-fibrin matrix in vitro. The S. sanguinis strain SK36 has been reported to bind platelets 
(56), but had not yet been shown to adhere to a platelet-fibrin matrix. Lactococcus lactis strain 
MG1363 is a food-grade, lactic acid-producing bacteria. It was chosen for testing as a possible 
negative control because it is non-pathogenic, does not colonize mammals, and it possesses a 
GRAS (generally regarded as safe) status (75, 77, 78). DH10B is a genetically engineered 
laboratory strain of E. coli. It also was chosen for testing as a possible negative control because it 
was thought to be unlikely to specifically bind a platelet-fibrin matrix.  
Percent bacterial adherence to a platelet-fibrin matrix is shown (Figure 7) as a function of 
increasing adhesion time (time in which matrixes were incubated in the presence of 3H-labeled 
bacteria before being washed to remove non-adherent cells). At each time point except for one, 
comparison of percent adherence of DH10B and MG1363 with that of SK36, which has been 
reported to adhere to platelets (56), showed no significant difference. At 30 minutes, adherence 
of DH10B was significantly greater (P<0.01, ANOVA) than that of SK36. For both SK36 and 
MG1363, all time points showed a significantly higher adherence at 120 minutes than at 15 
minutes (P<0.001, ANOVA), suggesting that more cells of each strain were adhering over time. 
The same comparison for DH10B determined that there was no significant difference between 
time points, suggesting that the level of adherence remained constant over time. The results show  
 38
 
 
 
 
 
Figure 7. Bacterial adherence of 3H-labeled cells to platelet-fibrin matrixes. Adherence is 
expressed as a percentage of the total number of bacterial CFUs added to the matrix. SK36 data 
were derived from three experiments.  DH10B and MG1363 data came from one experiment 
each. Mean % adherence + SD is shown. 
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that DH10B and MG1363 adherence to platelet-fibrin matrixes is equal to or greater than that of 
SK36 in this assay.   
 
S. sanguinis-platelet adhesion 
 
Because we were unable to demonstrate greater binding of SK36 compared to that of 
negative control strains by measuring adherence of radioactively labeled cells to a platelet-fibrin 
matrix, we next decided to measure adhesion of purified platelets to bacteria immobilized on 
polystyrene wells, as has been done previously (56, 60). For this assay, platelets were purified 
from freshly collected, whole blood by gel filtration. They were then added to microtiter plates 
which had been previously coated with SK36 or another bacterial strain. After washing, the 
relative number of adherent platelets in each sample were determined by measurement of the 
intracellular platelet enzyme, acid phosphatase. Adherent platelets were lysed with a solution 
containing a substrate for acid phosphatase, which develops a soluble yellow product when it 
reacts with the enzyme. Absorbance of the resulting color in the wells was read at 410nm with a 
plate reader and used as a measure of platelet adherence. Using this assay, it was previously 
reported that SK36 adhered well to platelets and VT1614 did not (56). Therefore, we tested 
SK36 and VT1614 in the platelet-adhesion assay. Figure 8 shows platelet adherence to 
polystyrene wells coated with different bacterial strains. Platelets adhered significantly less well 
to wells coated with VT1614 than to wells coated with SK36, as expected. Since these results 
were consistent with previous findings, we continued to use the assay. 
As with the bacterial – platelet-fibrin matrix adhesion assay described above, a standard 
curve was developed. This was done to determine the relationship between a measured 
absorbance value and the corresponding number of adherent platelets, thus providing a more  
 41
 
 
 
 
 
Figure 8. Platelet adhesion to polystyrene wells coated with immobilized bacteria. Adherent 
platelets were lysed with a solution containing a substrate for the platelet enzyme, acid 
phosphatase, resulting in a color change within the wells. Contents of the wells were diluted 1:4 
and light absorbance was read at 410nm on a plate reader. Values shown (mean absorbance + SD) 
are from 3 replicates in one experiment. Asterisk indicates an absorbance significantly different 
from SK36 (P<0.05). 
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quantitative measure of platelet adherence. First, the number of platelets in the original gel-
filtrate were manually counted under a phase contrast microscope (40X objective). Next, the gel-
filtered platelets were serially diluted in the polystyrene wells and combined with the platelet-
lysing/acid phosphatase substrate solution. Finally, the absorbance of the resulting 
 color was measured as before. Figure 9 is a standard curve from a single S. sanguinis-platelet-
adhesion experiment and shows the measured absorbancies from wells with increasing 
concentrations of platelets. A trendline was inserted into the graph. The equation from the 
trendline was used in a corresponding S. sanguinis-platelet-adhesion experiment to convert 
measured absorbance to number of platelets adherent to bacteria-coated wells. Subsequently, 
platelet adherence to the S. sanguinis-coated polystyrene wells was expressed as the percentage 
of adherent platelets divided by the total number of platelets added.   
 After establishing that platelets adhered to SK36 in this assay and that we could measure 
their adhesion, we examined platelet adhesion to 12 different Cwa protein mutants, each missing 
a single Cwa protein (Tables 1 and 2). SK36 has 33 predicted Cwa proteins and the 12 individual 
Cwa protein mutant strains tested in this study were all derived from SK36. Table 2 shows the 
Streptococcus sanguinis mutants used in this study, and provides descriptions of their functions 
or the functions of their orthologs in other bacterial species. All of the mutants, with the 
exception of VT1614 (56), were created previously in our lab (67).  
Tested strains were separated into two groups because it was too cumbersome to run 
experiments with all of them at once. SK36 was tested alongside each of the two groups. Percent 
platelet adherence to immobilized S. sanguinis is shown in Figure 10. Polystyrene wells coated 
with VT1614 had a significantly lower percentage of adherent platelets than did wells coated 
with SK36 (P<0.01, ANOVA). This was the only strain that differed significantly from SK36.  
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Figure 9. Standard curve from a single S. sanguinis-platelet-adhesion experiment. Serially 
diluted gel-filtered platelets were combined with a platelet-lysing solution containing the 
chromogenic acid phosphatase substrate, p-nitrophenol phosphate. The absorbance of the 
resulting colored solution was measured at 410nm. The concentration (platelets mL-1) of added 
platelets was determined prior to the reaction by manual counting under a phase contrast 
microscope.  
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 Table 2. Streptococcus sanguinis cell-wall anchored protein mutants used and descriptions 
of predicted S. sanguinis cell wall-anchored proteins 
This table was adapted from (67). 
         
Cwa 
Mutant 
Missing 
Protein 
Gene ID Gene Ortholog Bacterium  Description of  S. sanguinis 
missing protein or 
orthologous protein 
VT1614 SrpA SSA_0829 srpA  
 
hsa 
S. sanguinis 
 
S. gordonii 
Platelet binding & aggregation 
(56) 
 
Platelet binding (55), 
endocarditis virulence (45), 
binding to gp340 and HEP-2 
epithelial cells (79)  
13 SspC SSA_0303 sspC sspA, 
sspB 
S. gordonii Antigen I/II, promotes binding 
to collagen (80); binding to 
gp340 (79) 
      spaP, 
pac 
S. mutans Adherence to fibronectin, 
collagen and fibrinogen (81); 
adherence to gp340 (82) 
33 CrpA SSA_0904 crpA  cshA S. gordonii Platelet adhesion (62); 
adherence to immobilized 
fibronectin (44) 
9 SspD SSA_0956 sspD sspA, 
sspB 
S. gordonii Antigen I/II, promotes binding 
to collagen, dentinal tubule 
invasion (80); binding to 
gp340 (79) 
15  SSA_1023   vwb1 S. 
lugdunensis 
Von Willebrand factor (vWF) 
binding protein (83) 
25  SSA_1063       Contains Von Willebrand 
factor type A domain, 
cd00198 (84) 
8 
7 
6 
 
 SSA_1632 
SSA_1633 
SSA_1634 
SSA_1635 
 rrgA, 
rrgB 
S. 
pneumoniae 
Surface pilus locus; Pili linked 
to in vitro adherence to A549 
epithelial cells, colonization 
and virulence in vivo (85) 
3 CbpA SSA_1663 cbpA  S. sanguinis Platelet aggregation (62); 
vegetation enlargement 
(54)/collagen binding domain, 
pfam05737 (84) 
30  SSA_1666   S. sanguinis Contains collagen binding 
domain, pfam05737 (84) 
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Figure 10. Platelet adhesion to S. sanguinis-coated polystyrene surface. Platelet adherence to S. 
sanguinis mutants in group 1 (A.) and group 2 (B.) is expressed as a percentage relative to SK36. 
The values (mean + SD) are from three replicates each in three independent experiments. 
Asterisks indicate percent adherence significantly different from SK36 (** P<0.01). 
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This result suggested that gel-filtered platelets adhere less well to VT1614 than SK36 but equally 
well to the other mutant strains. 
 
S. sanguinis adherence to a polystyrene surface 
The first step in the S. sanguinis-platelet-adhesion assay is immobilization of bacterial 
cells on a polystyrene surface. It was previously observed that VT1614 attached poorly to 
polystyrene plates following overnight incubation (67). This suggested an alternative explanation 
for our observation of poor platelet binding to strain VT1614. Perhaps the cells of this strain 
bound platelets just as efficiently as SK36, but because fewer cells were binding to the plate, 
fewer platelets were binding. Therefore, in order to determine the amount of bacterial adherence 
to the polystyrene wells, a whole-cell bacterial ELISA was performed. S. sanguinis cells were 
prepared and allowed to adhere to polystyrene wells, as in the S. sanguinis-platelet adhesion 
assay. Adherent cells were treated with an anti-SK36 polyclonal antiserum (67), followed by 
alkaline phosphatase-conjugated anti-rabbit immunoglobulin G as a secondary antibody. Bound 
antibody was detected by addition of p-nitrophenyl phosphate substrate, which produced a 
soluble yellow product upon reaction with alkaline phosphatase. Absorbance at 410nm of the 
resulting colored solution was measured on a plate reader.  
Rather than using absorbance as a measure of bacterial adherence, a standard curve was 
developed in each ELISA. This was done in order to determine the relationship between a 
measured absorbance value and the corresponding number of bacterial CFUs adherent to a 
polystyrene well, as well as provide a more quantitative measure of bacterial adherence. A SK36 
culture of known concentration (CFU mL-1) was serially diluted. The diluted cells were allowed 
to adhere to the polystyrene wells. Immunodetection of adherent cells was performed as 
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described in Materials and Methods. Figure 11 shows a standard curve from a single whole-cell 
bacterial ELISA and indicates the absorbance from wells with increasing concentrations of added 
bacteria. A trendline was inserted into the graph. The equation from the trendline was used to 
convert measured absorbance to number of bacterial CFUs adherent to the polystyrene wells. 
Subsequently, bacterial adherence to polystyrene wells was expressed as the percentage of 
adherent CFUs out of the total number of CFUs originally added. 
Twelve different S. sanguinis CWA mutants (Table 2) were tested alongside SK36 for 
their ability to adhere to polystyrene wells. Percent adherence is shown (Figure 12). Eight of the 
12 mutants, including VT1614, adhered significantly less well to the polystyrene surface than did 
SK36 (ANOVA). This reproduced the reduced-adhesion phenotype previously reported for 
VT1614 (67). Since an equal number of adherent cells of each strain in the polystyrene wells is 
important for the S. sanguinis-platelet-adhesion assay, these results presented a potential 
problem. We therefore attempted to fix cells chemically to the polystyrene surface in equal 
numbers between strains. This was based on the previous finding from our lab that VT1614 cells 
could be fixed to the plate surface in numbers equal to SK36 by glutaraldehyde treatment (67). 
However, incorporation of this treatment into the platelet-adhesion assay resulted in a significant 
increase (P<0.05, Unpaired t test) in the amount of platelets adherent to background wells coated 
with 2% BSA (w/v) (measured by absorbance at 410nm). This suggested the glutaraldehyde was 
affecting platelet adherence to the polystyrene wells. Moreover, glutaraldehyde treatment 
reduced binding of platelets to SK36. This suggested the treatment was eliminating specific 
binding of platelets by SK36. For these reasons, the treatment was abandoned and another 
approach was used to account for differences in the number of cells adherent to the plate surface. 
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Figure 11. Standard curve from a single whole-cell bacterial ELISA. Serially diluted SK36 cells 
from a culture of known concentration (CFU ml-1) were added to polystyrene wells.  
Immunodetection of adherent cells was measured via absorbance at 410nm. 
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Figure 12. S. sanguinis adhesion to a polystyrene surface. A whole-cell ELISA was performed 
on S. sanguinis adherent to a polystyrene surface. Bacterial adherence of S. sanguinis Cwa 
protein mutants in group 1 (A.) and group 2 (B.) is expressed as a percentage relative to SK36 
adherence. The values (mean + SD) are from three replicates in three independent experiments. 
Asterisks indicate percent adherence significantly different from SK36 (* P<0.05; ** P<0.01) 
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Combining platelet adherence and ELISA data  
 
 Because we could not ensure equal adherence of different strains to the plate surface, we 
decided to measure adherence of each strain and then adjust for these differences when 
measuring bound platelets. The whole-cell bacterial ELISA was therefore performed 
simultaneously with the S. sanguinis-platelet-adhesion assay. The results of both sets of 
experiments, described above, are shown side by side in Figure 13. To account for the variation 
between mutant strains in the number of bacterial CFUs adherent to the polystyrene surface, 
adhesion percentages from the ELISA experiments were divided into adhesion percentages from 
the S. sanguinis-platelet-adhesion experiments, as was described in Materials and Methods. The 
resulting, adjusted values for platelet adherence are shown (Figure 14). None of the tested 
mutants differed significantly from SK36 in their ability to bind platelets. 
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Figure 13. Platelet adhesion to S. sanguinis-coated polystyrene surface/S. sanguinis adhesion to 
a polystyrene surface. The results of the two separate sets of experiments are shown together. 
Two different types of adhesion are shown here: platelet-bacteria adhesion, and bacteria-plate 
adhesion. 
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Figure 14. Adjusted values for S. sanguinis-platelet adhesion. Platelet adherence to S. sanguinis 
mutants in group 1 (A.) and group 2 (B.) is expressed as a percentage relative to platelet-SK36 
adherence. The values (mean + SD) were obtained by dividing data from the whole cell ELISA 
experiments into data from S. sanguinis-platelet adhesion experiments. 
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Discussion 
 
Infective endocarditis remains a disease with high morbidity and mortality. Bacterial-
platelet adherence has been suggested to be an important early event in the pathogenesis of IE 
(47). Furthermore, there are multiple reports of S. sanguinis binding platelets in vitro (56, 58-61).  
Some bacterial Cwa proteins have been reported to contribute to platelet binding by gram-
positive bacteria (48-52, 55, 56, 62). Only two of these studies involved S. sanguinis Cwa 
proteins. (56, 62). Therefore, we set out to further this research and determine if multiple Cwa 
proteins contribute to S. sanguinis-platelet adhesion. To that end, we attempted to measure both 
bacterial adhesion to platelet-fibrin matrixes and platelet adhesion to polystyrene wells coated 
with immobilized S. sanguinis.  
It is unclear why an oral commensal bacteria, such as S. sanguinis, would play a benign 
or even beneficial role in the oral cavity, and a pathogenic role on the heart endothelium. 
Moreover, given that oral bacteria do not frequently encounter platelets in the oral cavity, it 
initially seems inexplicable why they would be able to interact with them at all, let alone 
colonize a platelet vegetation. It has previously been reported that the platelet membrane 
sialoglycoprotein GPIbα acts as the receptor for two strains of S. sanguinis (60), and that a 
serine-rich glycoprotein on the bacteria (SrpA) mediates this adhesion in a sialic-acid-dependent 
manner (56). In S. gordonii, the Hsa and GspB proteins have been shown to interact with certain 
sialylated salivary molecules, including the low-molecular-weight mucin, MG2 (86). A 
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relationship between the capability of oral viridans streptococci to interact with the platelet 
receptor, GPIbα, which they rarely encounter and their ability to interact with salivary proteins, 
which they routinely encounter has been reported. It was previously shown that platelet adhesive 
strains of S. sanguinis and S. gordonii that adhered to platelets in a GPIbα-dependant manner 
also bound to the low-molecular-weight submandibular salivary protein, MG2, and this 
interaction was sialic acid-dependent (87). Based on these collective results, it was suggested 
that S. sanguinis and S. gordonii may be efficient colonizers of platelet vegetations because of 
their adaptation to recognize sialylated salivary mucins (87). In the oral cavity, Fim A of S. 
parasanguinis is a recognized oral adhesin, which mediates adherence to the salivary pellicle. 
However, it is also reported to be a major virulence determinant in S. parasanguis endocarditis 
due to a potential role in initial colonization of damaged heart tissue (88). Reports such as these 
suggest that the naturally occurring adhesins of oral bacteria, which mediate bacterial adhesion in 
their normal niche, may be inadvertently binding to surfaces in the heart and contributing to the 
pathogenesis of IE. 
To examine bacterial adhesion to a platelet-fibrin matrix, our first approach utilized 
bacterial colony formation on the surface of a platelet-fibrin matrix as an indicator of bacterial 
adherence, as has been done before (57). We examined the presence of SK36 colonies in wells 
with and without platelet-fibrin matrixes and found similar numbers in both. Although only one 
experiment was performed, it appeared as though SK36 adhered equally well to the matrix and 
plate surface. The presence of SK36 colonies in the wells without matrixes was not surprising, as 
the ability of SK36 to adhere to a polystyrene surface has been used in assays by us and others 
(67). What stood out about this approach was how difficult it was to count the colonies. 
Countable numbers of colonies were observed in wells that were inoculated with fewer than 100 
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CFU mL-1. In our assay, the platelet-fibrin matrixes were prepared in 24-well polystyrene plates, 
with a well diameter of 16mm, rather than much larger 60mm diameter tissue culture dishes, 
previously used (57). We decided to do this for two reasons. Logistically, multiple matrixes on a 
single plate would have allowed for easier screening of a large number of Cwa mutant strains 
than would the larger, individual Petri dishes. Furthermore, the smaller wells allowed for the 
creation of smaller platelet-fibrin matrixes, which in turn, required less platelet-rich plasma. 
Because it was readily available, we had utilized PRP obtained from blood bank whole-blood for 
initial testing in this assay. Had we continued to use this assay, we would have used fresh PRP 
obtained from volunteer blood donors, which is a more commonly used source for in vitro 
bacterial adherence assays. Since we wanted to take as little as necessary from our potential 
blood donors, the amount of PRP used in our assay became important. However, the smaller size 
of the matrixes forced a smaller countable number of colonies.  
There is also a theoretical problem with using colony formation as an indicator for 
adherence. A bacterial colony is not an exact indicator of the number of adherent cells. In the 
case of S. sanguinis, which forms chains of cells, a single colony can arise from a single chain, a 
clump of chains, or even multiple unlinked chains present in close proximity. This approach only 
provides a qualitative measure of bacterial adherence. It does not measure the actual number of 
bacterial cells adhering to the platelet-fibrin matrix. 
Our next approach to examine bacterial adhesion to a platelet-fibrin matrix measured 
adherence of radioactively labeled cells by scintillation counting, as has been done previously 
(75). We determined that treatment of 3H-labeled SK36 with TS-2 tissue solubilizer, both in the 
presence and absence of platelet-fibrin matrixes, increased the sensitivity and reproducibility of 
3H detection in these samples. Based on microscopic examination, we believe this is due to 
 63
dispersing chains of cells as well as lysing whole cells, leading to a more homogeneous mixture 
in the scintillation fluid. This finding could be important for future studies measuring 3H-labeled 
S. sanguinis or other species by liquid scintillation counting. Examination of the literature 
revealed several studies which measured 3H-labeled bacteria via liquid scintillation counting that 
did not report a solubilization treatment in their methods (80, 89). These studies examined oral 
streptococcal species as well. Although this seems unlikely, it is possible that those species may 
not have required solubilization for stable and efficient 3H counting. In our own study, we did 
not examine the effect of TS-2 on detection of 3H-labeled MG1363 or DH10B. These strains are 
gram-positive diplococci and gram-negative rods, respectively, which don’t form chains and also 
may not have required solubilization for stable and efficient 3H counting. 
Upon examination of bacterial adherence to the platelet-fibrin matrixes, we were unable 
to find another bacterial species that adhered poorly compared to SK36. It is unclear why 
DH10B and MG1363 adherence was equal to or greater than that of SK36. Perhaps, not all of the 
measured CPM were the result of adherent 3H-labeled bacteria. It is possible that some cells 
could have lysed when incubated with the matrixes, allowing free [3H]thymidine or 
[3H]thymidine-containing nucleic acid to adhere to the matrix. Such a situation could have 
provided a false positive result. Another possibility is that the matrix surface is “sticky” and it 
may not have been possible to wash away our tested negative control species without also 
washing away the matrix. Finally, it is unlikely that our matrixes consisted of purely platelets 
and fibrin. Although they were washed, the matrixes were formed in the presence of platelet rich 
plasma, and their surfaces were likely covered in many plasma proteins that could potentially 
have been contributing to the proposed “stickiness.”  
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SK36 adherence to the matrixes varied considerably between experiments. Some of this 
variation could potentially be due to variability in matrix formation between experiments caused 
by different platelet counts in blood donors, as the platelet concentration of the PRP was not 
determined. It was previously suggested that platelet donor-specific polymorphisms may affect 
the potential for platelet aggregating strains of S. sanguinis to act as thrombogenic agents (62). 
Perhaps platelet donor-specific differences affected matrix formation and or bacterial adherence 
in our experiments.  However, this would not explain the intra-experimental variation in 
adherence exhibited by our negative control strains, which were compared side-by-side with 
matrixes formed by PRP from the same donor. Alternatively, variation in SK36 adherence could 
have been due to bacterial clumping on the matrix surface. It has previously been observed in our 
lab that SK36 is capable of forming large clumps of cells. If SK36 did form clumps prior to or 
during incubation with the matrixes, it is possible that this could have contributed to varying 
adherence. Sonication of cells prior to incubation with the matrixes may be one way to deter 
clump formation. 
The S. sanguinis-platelet adhesion assay was intended to employ equal numbers of cells 
adherent to the plate surface for each strain tested. By observing that not all S. sanguinis Cwa 
mutants adhere equally well to a polystyrene surface, our study has elucidated a potential 
problem with this previously used method for measuring platelet adherence to immobilized S. 
sanguinis (56). Because we were unable to obtain equal adherence of the strains to the matrixes, 
we attempted to correct for these differences when comparing platelet adherence. The correction 
may not have been entirely accurate, because it is possible that the relationship between cell 
number and platelet binding might not be linear. To illustrate this point, we do not know, for 
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example, whether a surface completely covered with cells will bind twice the number of platelets 
bound by a surface that is only half covered with cells.  
 Nevertheless, using this approach, we saw no significant difference in platelet adherence 
among strains. This appeared to conflict with results previously published by Plummer et al. who 
reported that VT1614 adhered very poorly to platelets in the same platelet adhesion assay we 
used (56). However, before accounting for differences in bacterial adhesion to the plate, our 
initial observation that platelets adhered significantly less well to VT1614 than SK36 was 
consistent with the previous finding by Plummer et al. (56). The most obvious explanation for 
this is that the previously mentioned study did not account for reduced VT1614 adherence to the 
plate surface, since this issue was not reported (56). If this was the case, the observed difference 
in platelet adherence between VT1614 and SK36 may be partially or entirely due to fewer 
VT1614 cells available on the plate surface to bind platelets.  
Our results show that none of the Cwa proteins missing in our tested mutants are 
individually required for platelet adhesion. This suggests that either the mutated Cwa proteins are 
not required for S. sanguinis-platelet adhesion or that functional redundancy masks the 
individual contributions of the Cwa proteins, as was previously suggested (67). In this case, an 
example of possible functional redundancy would be multiple Cwa proteins conferring the same 
platelet adhesion phenotype upon S. sanguinis. If a single one of the proteins is missing, others 
are still there to perform its function.  
If functional redundancy is occurring, one way to possibly reveal it would be to perform 
an experiment measuring platelet adhesion to a Cwa mutant deficient in multiple Cwa proteins. 
Another member of our lab has created several such mutants, the most notable being a srtA 
mutant (ref). The srtA gene in S. sanguinis encodes a putative cell membrane-bound enzyme 
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called sortase A (SrtA), which is the sortase responsible for anchoring the majority of Cwa 
proteins to the peptidoglycan layer of the bacterial cell wall via a trans-peptidation reaction (90-
92). If screening of the srtA mutant in a platelet adherence assay resulted in decreased platelet 
adhesion compared to the individual Cwa protein mutants, it would support the functional 
redundancy hypothesis. However, a different assay from ours would be required, given the 
problems with Cwa protein mutants adhering to a polystyrene surface.  
An alternative approach in which platelet-bacterial adhesion occurs in suspension, rather 
than on a surface has been previously reported (59), although this particular assay provides only 
a qualitative measure of adherence. As another option, qualitative analyses of staphylococcal and 
streptococcal-platelet adhesion using flow cytometry have been reported (61, 93). Approaches to 
measure bacterial-platelet binding such as these would circumvent the issue of mutant strains 
adhering less well to a polystyrene surface. Yet another approach would be to employ 
heterologous expression of Cwa proteins in MG1363, described previously (43, 50, 75), to 
screen for increased platelet adherence vs. the wild type. 
In our study, we examined mutants of 12 Cwa proteins with putative adhesion capability 
to different molecules (Table 2). Three of these Cwa proteins, SrpA, CbpA, and CrpA have 
previously been reported to interact with platelets, which made them obvious choices for further 
investigation in this study (56, 62). While the other nine Cwa proteins had not been reported to 
interact with platelets, what we did know about them (Table 2) suggested they might be relevant 
to platelet binding. 
The Cwa protein missing from Cwa mutant 25 shares homology with the vWF type-A 
domain, which has been reported to bind the platelet receptor glycoprotein Ib (GPIb) (94) and 
collagen (95). The predicted homolog for the missing protein in Cwa mutant 15 is the vWF 
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binding protein, vWf1, of Streptococcus lugdunensis (83). If this missing Cwa protein is, in fact, 
capable of binding vWF, perhaps a vWF multimer could act as a molecular bridge between the 
Cwa protein and the platelet receptor GPIb, which is a proposed model for the interaction of S. 
aureus protein A with platelets (34). Platelet granules contain many secretion products, including 
vWF, which are released upon activation. Although care was taken in our preparation of platelets 
for use in assay to avoid activation, and subsequent clumping, it is likely some did activate. 
Therefore, vWF could have been present to contribute to a potential bacteria-platelet interaction. 
An ortholog of the mutated SspC protein in Cwa mutant 13 promotes adherence to both 
fibronectin and the plasma protein fibrinogen (81). If our homologous Cwa protein can bind 
these host proteins, they may be able to act as a bridge between the Cwa protein and a platelet 
receptor, similar to the platelet interactions of the S. aureus proteins, clumping factor A (ClfA) 
and fibronectin binding protein A (FnbA) (34, 96). Although our gel filtered platelet technique 
(described in Materials and Methods) attempted to isolate platelets from plasma proteins, it 
probably did not eliminate all of these proteins. Furthermore the surface of the filtered platelets 
may have been covered in plasma proteins. Therefore, it is possible that fibrinogen may have 
been present to participate in such a bridging mechanism.  
The mutated Cwa proteins in mutants 13 and 9 are SspC and SspD, respectively. These 
proteins share sequence identity with the well characterized antigen I/II proteins of S. gordonii, 
SspA and SspB, which have been shown to promote binding to collagen (80) and glycoproteins 
in the oral cavity (79). Furthermore, the Cwa proteins missing in Cwa mutants 30 and 3 may also 
interact with collagen, as they share homology with a conserved collagen-binding domain. 
Perhaps these putative collagen adhesins can interact with platelets by mechanisms similar to 
that of platelet-collagen interactions (36, 37). 
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Finally, the mutated genes in Cwa mutants 6 through 8 and the SSA_1635 mutant are 
thought to encode proteins involved in the formation of a bacterial surface pilus. A pilus in 
another streptococcal species is an important adhesin. Expression of the previously characterized 
gram-positive surface pilus in Streptococcus pneumoniae was associated with colonization of 
A549 lung epithelial cells in vitro and a strong inflammatory response in vivo, suggesting the 
pilus contributes to adherence and virulence (85). Perhaps a S. sanguinis surface pilus would 
contribute to platelet adhesion. 
   The previously mentioned study by Turner et al. (67) was conducted by other members of 
our lab at the same time our study was being conducted. Turner et al. evaluated the role of S. 
sanguinis Cwa proteins in the development of IE. Virulence screening of thirty-three predicted 
cell wall-anchored protein mutants, including the 12 screened in our study, and three putative 
sortase mutants was performed in a rabbit model of IE. It was found that no single Cwa protein 
was essential for the development of early IE and that individual sortases of S. sanguinis play a 
minimal role in competitive colonization at the onset of IE (67). These very recent findings relate 
to our current study because they suggest that even if Cwa proteins were found to contribute to 
platelet binding by S. sanguinis, strategies designed to interfere with this interaction would not 
be effective for disease prevention. While we had previously been hoping that future prophylaxis 
strategies might interfere with S. sanguinis IE by blocking Cwa protein-mediated adhesion to 
platelets, it appears this isn’t a viable option. However, opsonization of bacteria by host protein-
Cwa protein interactions may still be a promising strategy. 
While we were unable to show that the Cwa proteins missing in our tested mutants 
contribute to S. sanguinis-platelet adhesion, our study has elucidated a potential problem with a 
previously used method for measuring platelet adherence to immobilized S. sanguinis. If future 
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studies cannot find a way to ensure equal adherence of tested strains to a polystyrene surface, a 
different adhesion assay should be used. Also, our study has shown that treatment of 3H-labeled 
S. sanguinis with a chemical solubilizer is important to the efficiency and stability of tritium 
detection by liquid scintillation counting. With respect to S. sanguinis-platelet adhesion, further 
study is required to determine the mechanism(s) by which S. sanguinis adheres to platelets. 
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